Sacral Nerve Stimulation Therapy for the Treatment of Chronic Fecal Incontinence
Public ClinicalTrials.gov record NCT00200057. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Medtronic InterStim® Sacral Nerve Stimulation Therapy for Bowel Control: Fecal Incontinence Study
Study identification
- NCT ID
- NCT00200057
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- MedtronicNeuro
- Industry
- Enrollment
- 285 participants
Conditions and interventions
Conditions
Interventions
- InterStim Sacral Nerve Stimulation Therapy Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2001
- Primary completion
- Jul 31, 2007
- Completion
- Aug 31, 2011
- Last update posted
- Jan 23, 2013
2002 – 2011
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Contact Medtronic for specific site information | Los Angeles | California | — | — |
| Contact Medtronic for specific site information | San Francisco | California | — | — |
| Contact Medtronic for specific site information | Washington D.C. | District of Columbia | — | — |
| Contact Medtronic for specific site information | Weston | Florida | — | — |
| Contact Medtronic for specific site information | Chicago | Illinois | — | — |
| Contact Medtronic for specific site information | Kansas City | Kansas | — | — |
| Contact Medtronic for specific site information | New Orleans | Louisiana | — | — |
| Contact Medtronic for specific site information | Burlington | Massachusetts | — | — |
| Contact Medtronic for specific site information | Minneapolis | Minnesota | — | — |
| Contact Medtronic for specific site information | Cleveland | Ohio | — | — |
| Contact Medtronic for specific site information | Oklahoma City | Oklahoma | — | — |
| Contact Medtronic for specific site information | Fort Worth | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00200057, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 23, 2013 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00200057 live on ClinicalTrials.gov.